×
Merck Total Assets 2012-2026 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Merck total assets for the quarter ending March 31, 2026 were
$129.546B
, a
10.22% increase
year-over-year.
Merck total assets for 2024 were
$117.106B
, a
9.78% increase
from 2023.
Merck total assets for 2023 were
$106.675B
, a
2.28% decline
from 2022.
Merck total assets for 2022 were
$109.16B
, a
3.28% increase
from 2021.
View More
Merck Total Assets 2012-2026 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Merck total assets for 2024 were
$117.106B
, a
9.78% increase
from 2023.
Merck total assets for 2023 were
$106.675B
, a
2.28% decline
from 2022.
Merck total assets for 2022 were
$109.16B
, a
3.28% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
AbbVie (ABBV)
$367.7B
Roche Holding AG (RHHBY)
$318.8B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B
Innoviva (INVA)
$1.8B